ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryPlan-Les-OuatesVaccine Formulation Institute SA
Vaccine Formulation Institute SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Vaccine Formulation Institute (VFI) is the development and provision of adjuvants and vaccine formulations for global health. The company supports the vaccine community by providing adjuvants and formulation expertise, supports the development of adjuvanted vaccines up to industrial scale, and helps donors and funders implement vaccine development programs.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered5
Adjuvant Development and Supply
Adjuvant development and supply for research, preclinical and clinical use, including oil-in-water emulsions, liposomes and mineral salts, with advice on formulation and evaluation.
Vaccine Formulation Optimisation and Characterisation
Optimisation and characterisation of adjuvanted vaccine formulations to improve stability, physical, chemical and biological properties, and the immune responses they induce.
Manufacturing and Quality Control Technology Transfer
Technology transfer for adjuvant manufacturing and quality control, including assays, technology and equipment, plus installation and training for manufacturers.
Training in Adjuvants and Vaccine Formulations
Theoretical and practical training courses on adjuvants and vaccine formulation, offered regularly and also customised on request.
Adjuvant and Formulation Support for Vaccine Developers
Support for academic, industrial and funding partners in vaccine development, adjuvant research, preclinical development and project execution.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Vaccine Formulation Institute SA

Trust & reputation

ranQ Trust Score of Vaccine Formulation Institute SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Vaccine Formulation Institute SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Vaccine Formulation Institute SA scores 79.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Vaccine Formulation Institute SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Vaccine Formulation Institute SA scores 60.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.60.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Vaccine Formulation Institute SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Vaccine Formulation Institute SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Vaccine Formulation Institute SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Vaccine Formulation Institute SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Vaccine Formulation Institute SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Rue du Champ-Blanchod 4
1228 Plan-Les-Ouates

At a glance

Legal form
Corporation
UID
CHE-391.264.652
Founded
2020 · 6 years
Last commercial register change
August 3, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    KB
    KBI Biopharma SA
    Plan-Les-Ouates
    HS
    HEKETISS SA
    Plan-Les-Ouates
    NS
    NovImmune SA
    Plan-Les-Ouates
    SD
    SOLID Drug Development SA
    Geneva
    IH
    IQONE HEALTHCARE SWITZERLAND SA
    Versoix
    SS
    Santen SA
    Geneva
    LL
    Luminar Life Sciences SA
    Vandoeuvres
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin